Canton, Mass.-based advanced wound care innovation and technologies developer Organogenesis has secured a financing facility worth $20 million from Eastward Capital Partners. The money will be used for the continued enhancement of the company's product portfolio.
Eastward Capital provides $20M facility to Organogenesis
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.